These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 199098)

  • 1. Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis.
    Lieberman J; Rea TH
    Ann Intern Med; 1977 Oct; 87(4):423-5. PubMed ID: 199098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lysozyme in leprosy.
    Naik SS; Gurnani S
    Lepr India; 1980 Oct; 52(4):501-7. PubMed ID: 7464056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum angiotensin-converting enzyme in leprosy.
    Dhople AM; Howell PC; Williams SL; Zeigler JA; Storrs EE
    Indian J Lepr; 1985; 57(2):282-7. PubMed ID: 3001195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampin therapy of lepromatous leprosy.
    Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 6. The therapeutic effect of 4,4'-diacetyldiamino-diphenylsulfone (DADDS) in leprosy.
    Shepard CC; Tolentino JG; McRae DH
    Am J Trop Med Hyg; 1968 Mar; 17(2):192-201. PubMed ID: 4870563
    [No Abstract]   [Full Text] [Related]  

  • 7. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
    Garraud O; Ribierre O; Bach MA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and tissue lysozyme in leprosy.
    Rea TH; Taylor CR
    Infect Immun; 1977 Dec; 18(3):847-56. PubMed ID: 591069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of serum angiotensin-converting enzyme as a marker of activity in sarcoidosis: a study of 31 patients with erythema nodosum.
    Teirstein AS; Krumholtz S
    Mt Sinai J Med; 1987 Feb; 54(2):144-6. PubMed ID: 3033477
    [No Abstract]   [Full Text] [Related]  

  • 10. Soluble serum interleukin 2 receptor levels in leprosy patients.
    Tung KS; Umland E; Matzner P; Nelson K; Schauf V; Rubin L; Wagner D; Scollard D; Vithayasai P; Vithayasai V
    Clin Exp Immunol; 1987 Jul; 69(1):10-5. PubMed ID: 3115652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum macrophage migration inhibition activity in patients with leprosy.
    Rea TH; Yoshida T
    J Invest Dermatol; 1982 Nov; 79(5):336-9. PubMed ID: 6752294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM antibodies against phenolic glycolipid I from Mycobacterium leprae in leprosy sera: relationship to bacterial index and erythema nodosum leprosum.
    Schwerer B; Meeker HC; Sersen G; Levis WR
    Acta Leprol; 1984; 2(2-4):394-402. PubMed ID: 6398598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy.
    Touw Langendijk EJ; van Diepen TW; Harboe M; Belehu A
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):305-11. PubMed ID: 6358061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriological status (point prevalence) of lepromatous outpatients under sulfone treatment.
    Quagliato R; Bechelli LM; Almeida JO; Araujo Arantes MA
    Bull World Health Organ; 1975; 52(1):57-62. PubMed ID: 764995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z; Sbai M; Elhaouri M; Bouzidi A; Boudi O; Ghfir M; Benomar S; Sedrati OL
    Acta Leprol; 2003; 12(3):107-11. PubMed ID: 15040700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta-glucuronidase in subtypes of leprosy.
    George J; Rajendran M; Bhatia VN
    Indian J Med Res; 1990 Mar; 91():106-10. PubMed ID: 2345017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.